Investor Relations

Heartflow is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. We believe that we are the most widely adopted AI-powered test for CAD. Our novel Heartflow Platform leverages AI and advanced computational fluid dynamics to create a personalized 3D model of a patient’s heart from a single coronary computed tomography angiography (“CCTA”), a specialized type of scan that provides detailed images of the heart’s arteries. The Heartflow Platform delivers actionable insights on blood flow, stenosis, plaque volume and plaque composition, thereby overcoming the limitations of traditional non-invasive imaging tests which rely on indirect measures of coronary disease and lead to higher false negative and false positive rates.